Uri Ben-or - Net Worth and Insider Trading

Uri Ben-or Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Uri Ben-or owns 4 companies in total, including BiomX Inc (PHGE.U) , BiomX Inc (PHGE) , and Nuvectis Pharma Inc (NVCT) among others .

Click here to see the complete history of Uri Ben-or’s form 4 insider trades.

Insider Ownership Summary of Uri Ben-or

Ticker	Comapny	Transaction Date	Type of Owner
PHGE.U	BiomX Inc	2019-10-30	director
PHGE	BiomX Inc	2019-10-30	director
NVCT	Nuvectis Pharma Inc	2022-02-08	Int. Principal Financial Off.
		2023-01-01	Chief Financial Officer

Uri Ben-or Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Uri Ben-or Ownership Network

Ownership Network List of Uri Ben-or

No Data

Ownership Network Relation of Uri Ben-or

Uri Ben-or Owned Company Details

What does BiomX Inc do?

Who are the key executives at BiomX Inc?

Uri Ben-or is the director of BiomX Inc. Other key executives at BiomX Inc include 10 percent owner Kerry Propper , 10 percent owner Mountain Wood Llc , and Principal Financial Officer Marina Wolfson .

BiomX Inc (PHGE.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BiomX Inc (PHGE.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BiomX Inc (PHGE.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

BiomX Inc Insider Transactions

No Available Data

What does BiomX Inc do?

Who are the key executives at BiomX Inc?

Uri Ben-or is the director of BiomX Inc. Other key executives at BiomX Inc include director & 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , Chief Business Officer Assaf Oron , and 10 percent owner Carl L Gordon .

BiomX Inc (PHGE) Insider Trades Summary

Over the past 18 months, Uri Ben-or made no insider transaction in BiomX Inc (PHGE). Other recent insider transactions involving BiomX Inc (PHGE) include a net sale of 0 shares made by Assaf Oron , and a net purchase of 323,656 shares made by Orbimed Israel Biofund Gp Limited Partnership .

In summary, during the past 3 months, insiders sold 24,344 shares of BiomX Inc (PHGE) in total and bought 0 shares, with a net sale of 24,344 shares. During the past 18 months, 35,258 shares of BiomX Inc (PHGE) were sold and 358,914 shares were bought by its insiders, resulting in a net purchase of 323,656 shares.

BiomX Inc (PHGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

BiomX Inc Insider Transactions

No Available Data

What does Nuvectis Pharma Inc do?

Who are the key executives at Nuvectis Pharma Inc?

Uri Ben-or is the Int. Principal Financial Off. of Nuvectis Pharma Inc. Other key executives at Nuvectis Pharma Inc include director & Chairman & CEO Ron Bentsur , Chief Development Officer Shay Shemesh , and Chief Science and Business Off Enrique Poradosu .

Nuvectis Pharma Inc (NVCT) Insider Trades Summary

Over the past 18 months, Uri Ben-or made no insider transaction in Nuvectis Pharma Inc (NVCT). Other recent insider transactions involving Nuvectis Pharma Inc (NVCT) include a net purchase of 20,965 shares made by Ron Bentsur , a net purchase of 202,124 shares made by Marlio Charles Mosseri , and a net purchase of 2,033 shares made by Shay Shemesh .

In summary, during the past 3 months, insiders sold 0 shares of Nuvectis Pharma Inc (NVCT) in total and bought 10,553 shares, with a net purchase of 10,553 shares. During the past 18 months, 0 shares of Nuvectis Pharma Inc (NVCT) were sold and 226,122 shares were bought by its insiders, resulting in a net purchase of 226,122 shares.

Nuvectis Pharma Inc (NVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nuvectis Pharma Inc Insider Transactions

No Available Data

What does Scinai Immunotherapeutics Ltd do?

Who are the key executives at Scinai Immunotherapeutics Ltd?

Uri Ben-or is the Chief Financial Officer of Scinai Immunotherapeutics Ltd. Other key executives at Scinai Immunotherapeutics Ltd include director & other: Chairman Mark Germain , Chief Scientist Tamar Ben-yedidia , and director & Chief Executive Officer Amir Reichman .

Scinai Immunotherapeutics Ltd (SCNI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Scinai Immunotherapeutics Ltd (SCNI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Scinai Immunotherapeutics Ltd (SCNI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Scinai Immunotherapeutics Ltd (SCNI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scinai Immunotherapeutics Ltd Insider Transactions

No Available Data

Uri Ben-or Mailing Address

Above is the net worth, insider trading, and ownership report for Uri Ben-or. You might contact Uri Ben-or via mailing address: C/o Biomx Ltd., 7 Pinhas Sapir St., Floor 2, Ness Ziona L3 7414002.

Discussions on Uri Ben-or

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.